BioXcel Therapeutics
BTAI
#10164
Rank
S$47.32 M
Marketcap
S$1.53
Share price
-0.83%
Change (1 day)
-27.34%
Change (1 year)

Market capitalization of BioXcel Therapeutics (BTAI)

Market cap: S$47.32 Million

As of June 2026 BioXcel Therapeutics has a market cap of S$47.32 Million. This makes BioXcel Therapeutics the world's 10164th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BioXcel Therapeutics from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026S$47.32 M1.54%
2025S$46.6 M84.79%
2024S$25.22 M-77.88%
2023S$0.11 B-85.87%
2022S$0.80 B4.93%
2021S$0.76 B-48.47%
2020S$1.49 B318.89%
2019S$0.35 B331.33%
2018S$82.59 M

End of Day market cap according to different sources

On Jun 16th, 2026 the market cap of BioXcel Therapeutics was reported to be:

S$47.72 Million
by Nasdaq info icon info icon
S$47.72 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
S$1.15 B 2,331.28%๐Ÿ‡บ๐Ÿ‡ธ USA